Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts Finlay Minerals Announces Increase in Size of Non-Brokered Private Placement of Flow-Through Shares and Non-Flow-Through Units June 5, 2025 Satellite Imagery and Gold Exploration June 5, 2025 Scoping Study Demonstrates Low Cost ISR Uranium Potential June 5, 2025
Finlay Minerals Announces Increase in Size of Non-Brokered Private Placement of Flow-Through Shares and Non-Flow-Through Units June 5, 2025